Clinical Trials Logo

Controls clinical trials

View clinical trials related to Controls.

Filter by:
  • None
  • Page 1

NCT ID: NCT05118711 Recruiting - Controls Clinical Trials

Sequelae of COVID-19 With Focus on Exercise Capacity and Underlying Mechanisms

COR-PHYS
Start date: January 3, 2023
Phase:
Study type: Observational

The project is designed as a cross-sectional study and aims to examine long-term consequences of coronavirus disease 2019 (COVID-19) for selected bio-behavioural parameters while taking the disease course severity into account.

NCT ID: NCT04714788 Not yet recruiting - Controls Clinical Trials

A Mobile App to Improve Participation in Following-up Cohorts

Start date: February 2021
Phase: N/A
Study type: Interventional

The main objective is to test the superiority of a newly developed mobile application - RECAP_MyLife - for data collection in cohort studies in order to increase participation in follow-up evaluations. We hypothesize that data collection through a mobile app will contribute to improvements in participation. An accurate assessment of the potential benefits and drawbacks of using this mobile technology tool for data collection in cohort studies will be conducted. For such, the study will be conducted in three cohorts developed in different temporal, cultural, and geographic contexts, increasing the generalization of the results found. This evaluation is intended to contribute to the development of more appropriate tools for data collection and consequently to increase participation in epidemiological studies.

NCT ID: NCT04201470 Completed - Multiple Sclerosis Clinical Trials

Serum Neurofilaments and GFAP in Atypical Multiple Sclerosis

AMIS
Start date: December 9, 2019
Phase: N/A
Study type: Interventional

Idiopathic inflammatory disorders of the central nervous system include various disorders of which multiple sclerosis is the most common. Besides multiple sclerosis, other distinct disorders including for example anti-AQP4 (aquaporine-4) and anti-MOG (Myelin oligodendrocyte glycoprotein) NMOSD (Neuromyelitis optica spectrum disorder) have been well characterized and are now known to be distinct from MS. some patient belonging to MS spectrum have recently being characterized but unusual MRI findings have mimicking inherited leukoencephalopathies and leukodystrophies. Whether these patients with atypical phenotype represent a separate disease distinct from MS or belong to MS spectrum is not clear. The objectives are to evaluate a series of 15 patients with atypical forms of MS using non-conventional MRI techniques and biological biomarkers (serum neurofilaments light chain) and to compare them with classical MS patients (15 relapsing remitting patients and 15 progressive patients) and 15 controls. the hypothesize is that these patients with atypical MS have a more severe neurodegenerative process.

NCT ID: NCT03680885 Completed - ADHD Clinical Trials

Validating a New Non-invasive Approach to Testing Lidocaine Effectiveness

Start date: August 1, 2019
Phase: Early Phase 1
Study type: Interventional

This work will assess the reliability of a simple painless test for the effectiveness of the commonly used local anesthetic lidocaine

NCT ID: NCT02471625 Active, not recruiting - Clinical trials for Traumatic Brain Injury

Traumatic Brain Injury Feasibility Study (EPIC-011)

TBI
Start date: April 2015
Phase: N/A
Study type: Observational

The purpose of this research study is to evaluate whether data made by the ClearView System can be used to detect whether someone has a traumatic brain injury and how severe the injury is.